Nephros Inc (NEPH):企業の財務・戦略的SWOT分析

◆英語タイトル:Nephros Inc (NEPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14460
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended to be used to filter water and bicarbonate concentrate used in hemodialysis devices to assist in providing hemodialysis quality water or bicarbonate concentrates. The company offers infection control filters such as ice machine solutions, shower solutions and sink products. Its products are used in conjunction with other water treatment equipment. Nephros dialysis products are used in removal of biological contaminants. The company markets its products through a network of distributors in the US. Nephros is headquartered in South Orange, New Jersey, the US.

Nephros Inc Key Recent Developments

Feb 11,2019: Nephros names Alisa Lask to its Board of Directors
Jan 09,2019: Nephros announces preliminary financial results for fiscal year 2018
Nov 08,2018: Nephros reports third quarter 2018 financial results
Aug 13,2018: Nephros appoints Oliver Spandow to its board of directors
Aug 08,2018: Nephros reports second quarter 2018 financial results

This comprehensive SWOT profile of Nephros Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nephros Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nephros Inc – Key Information
Nephros Inc – Overview
Nephros Inc – Key Employees
Nephros Inc – Key Employee Biographies
Nephros Inc – Key Operational Heads
Nephros Inc – Major Products and Services
Nephros Inc – History
Nephros Inc – Company Statement
Nephros Inc – Locations And Subsidiaries
Nephros Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nephros Inc – Business Description
Nephros Inc – Corporate Strategy
Nephros Inc – SWOT Analysis
SWOT Analysis – Overview
Nephros Inc – Strengths
Nephros Inc – Weaknesses
Nephros Inc – Opportunities
Nephros Inc – Threats
Nephros Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Nephros Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nephros Inc, Key Information
Nephros Inc, Key Ratios
Nephros Inc, Share Data
Nephros Inc, Major Products and Services
Nephros Inc, History
Nephros Inc, Key Employees
Nephros Inc, Key Employee Biographies
Nephros Inc, Key Operational Heads
Nephros Inc, Other Locations
Nephros Inc, Subsidiaries
Nephros Inc, Key Manufacturing facilities
Nephros Inc, Key Competitors
Nephros Inc, SWOT Analysis
Nephros Inc, Ratios based on current share price
Nephros Inc, Annual Ratios
Nephros Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nephros Inc, Performance Chart
Nephros Inc, Ratio Charts

★海外企業調査レポート[Nephros Inc (NEPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New York Blood Center:製薬・医療:M&Aディール及び事業提携情報
    Summary New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization's blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical servic …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The Scripps Research Institute:企業のM&A・事業提携・投資動向
    The Scripps Research Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Scripps Research Institute Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • StarTek Inc (SRT):企業の財務・戦略的SWOT分析
    Summary StarTek Inc (StarTek) is a business process outsourcing company that offers contact center and customer engagement solutions. The company offers service solutions, technology solutions and customer experience suppor. Its service solution provides multi-channel customer interactions across vo …
  • Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterili …
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):企業の財務・戦略的SWOT分析
    China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the …
  • Digi International, Inc. (DGII):企業の財務・戦略的SWOT分析
    Digi International, Inc. (DGII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Daido Steel Co., Ltd.:企業の戦略・SWOT・財務分析
    Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Harsoria Healthcare Pvt Ltd:企業の戦略的SWOT分析
    Harsoria Healthcare Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務情報
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Event Hospitality & Entertainment Limited:戦略・SWOT・企業財務分析
    Event Hospitality & Entertainment Limited - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Shaheen Insurance Company Limited:企業の戦略・SWOT・財務情報
    Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • Shinko Electric Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • TechnologyOne Ltd (TNE):企業の財務・戦略的SWOT分析
    TechnologyOne Ltd (TNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆